Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

September 18, 2019

<div data-experience="5d7aafbe36cb1c0021630fa5">  📄 Download PDF of Client Alert  The Nagoya Protocol on Access and Benefit Sharing is the main global mechanism to regulate the access and utilization of biological resources. The agreement entered into force nearly five years ago, on October 12, 2014, as a supplement to the 1992 Convention on Biological ...

September 16, 2019, Covington Alert

Over the summer, Ursula von der Leyen, President-elect of the European Commission since July 16, prepared her 27-member Commission. On September 10, she presented her new team – five years to the day from when Jean Claude Juncker presented the current Commission. If approved by the European Parliament, her new team will take office on November 1, 2019. This ...

September 12, 2019, Covington Alert

This e-alert is part of a series of e-alerts summarizing publicly available FDA enforcement letters (i.e., warning letters and untitled letters) relating to the advertising and promotion of prescription drugs, medical devices, and biologics. In July and August, the Office of Prescription Drug Promotion (OPDP) posted enforcement letters on FDA’s website.

September 10, 2019, Covington Alert

The U.S. Department of the Treasury is expected to issue soon proposed regulations implementing the Foreign Investment Risk Review Modernization Act (“FIRRMA”), legislation enacted in August 2018 that reformed the Committee on Foreign Investment in the United States (“CFIUS” or the “Committee”).

September 9, 2019, Covington Alert

On August 26, 2019, China’s Standing Committee of National People's Congress (“NPC) adopted a significant revision of the Drug Administration Law (“DAL”). The newly adopted DAL (“Revised DAL”) will go into effect on December 1, 2019. The Revised DAL is the first overhaul of the DAL since 2001.

September 5, 2019, Cyrus R. Vance Center for International Justice

September 5, 2019, The Association of Corporate Legal Departments (Tokyo)